JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 47:91-97, doi:10.1016/j.jacc.2005.08.051 (Published online 13 December 2005).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.08.051v1
47/1/91    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (41)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anwaruddin, S.
Right arrow Articles by Januzzi, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anwaruddin, S.
Right arrow Articles by Januzzi, J. L., Jr

CLINICAL RESEARCH: HEART FAILURE

Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement

Results From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

Saif Anwaruddin, MD*, Donald M. Lloyd-Jones, MD, ScM, FACC{dagger}, Aaron Baggish, MD*, Annabel Chen, MD*, Daniel Krauser, MD*, Roderick Tung, MD*, Claudia Chae, MD, MPH, FACC* and James L. Januzzi, Jr, MD, FACC*,*

* Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
{dagger} Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Manuscript received June 10, 2005; revised manuscript received August 4, 2005, accepted August 9, 2005.

* Reprint requests and correspondence: Dr. James L. Januzzi, Jr., Massachusetts General Hospital, Yawkey 5984, 55 Fruit Street, Boston, Massachusetts 02114. (Email: JJanuzzi{at}Partners.org).

OBJECTIVES: We sought to examine the interaction between renal function and amino-terminal pro-brain natriuretic peptide (NT-proBNP) levels.

BACKGROUND: The effects of renal insufficiency on NT-proBNP among patients with and without acute congestive heart failure (CHF) are controversial. We examined the effects of kidney disease on NT-proBNP–based CHF diagnosis and prognosis.

METHODS: A total of 599 dyspneic patients with glomerular filtration rates (GFRs) as low as 14.8 ml/min were analyzed. We used multivariate logistic regression to examine covariates associated with NT-proBNP results and linear regression analysis to analyze associations between NT-proBNP and GFR. Receiver-operating characteristic analysis determined the sensitivity and specificity of NT-proBNP for CHF diagnosis. We also assessed 60-day mortality rates as a function of NT-proBNP concentration.

RESULTS: Glomerular filtration rates ranged from 15 ml/min/1.73 m2 to 252 ml/min/1.73m2. Renal insufficiency was associated with risk factors for CHF, and patients with renal insufficiency were more likely to have CHF (all p < 0.003). Worse renal function was accompanied by cardiac structural and functional abnormalities on echocardiography. We found that NT-proBNP and GFR were inversely and independently related (p < 0.001) and that NT-proBNP values of > 450 pg/ml for patients ages <50 years and >900 pg/ml for patients ≥50 years had a sensitivity of 85% and a specificity of 88% for diagnosing acute CHF among subjects with GFR ≥60 ml/min/1.73 m2. Using a cut point of 1,200 pg/ml for subjects with GFR <60 ml/min/1.73 m2, we found sensitivity and specificity to be 89% and 72%, respectively. We found that NT-proBNP was the strongest overall independent risk factor for 60-day mortality (hazard ratio 1.57; 95% confidence interval 1.2 to 2.0; p = 0.0004) and remained so even in those with GFR <60 ml/min/1.73 m2 (hazard ratio 1.61; 95% confidence interval 1.14 to 2.26; p = 0.006).

CONCLUSIONS: The use of NT-proBNP testing is valuable for the evaluation of the dyspneic patient with suspected CHF, irrespective of renal function.

Abbreviations and Acronyms
  BNP = B-type natriuretic peptide
  CHF = congestive heart failure
  CKD = chronic kidney disease
  ED = emergency department
  GFR = glomerular filtration rate
  IQR = interquartile range
  NT-proBNP = amino-terminal pro-brain natriuretic peptide
  PRIDE = ProBNP Investigation of Dyspnea in the Emergency Department study
  ROC = receiver-operating characteristic




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. W. Waldo, J. Beede, S. Isakson, S. Villard-Saussine, J. Fareh, P. Clopton, R. L. Fitzgerald, and A. S. Maisel
Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart Failure
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1874 - 1882.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2357 - 2368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. R. deFilippi, S. L. Seliger, S. Maynard, and R. H. Christenson
Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting Mortality
Clin. Chem., August 1, 2007; 53(8): 1511 - 1519.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W.H. Wilson Tang, G. S. Francis, D. A. Morrow, L. K. Newby, C. P. Cannon, R. L. Jesse, A. B. Storrow, R. H. Christenson, COMMITTEE MEMBERS, R. H. Christenson, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
Circulation, July 31, 2007; 116(5): e99 - e109.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
K.-S. Spanaus, F. Kronenberg, E. Ritz, R. Schlapbach, D. Fliser, M. Hersberger, B. Kollerits, P. Konig, A. von Eckardstein, and for the Mild-to-Moderate Kidney Disease Study Grou
B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study
Clin. Chem., July 1, 2007; 53(7): 1264 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Shadman, M. A. Allison, and M. H. Criqui
Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2172 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. R.J. van Kimmenade, J. L. Januzzi Jr, A. L. Baggish, J. G. Lainchbury, A. Bayes-Genis, A. M. Richards, and Y. M. Pinto
Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure: Redefining the Cardiorenal Interaction?
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. J. Shelton, A. L. Clark, K. Goode, A. S. Rigby, and J. G.F. Cleland
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
Eur. Heart J., October 1, 2006; 27(19): 2353 - 2361.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. M. Felker, J. W. Petersen, and D. B. Mark
Natriuretic peptides in the diagnosis and management of heart failure.
Can. Med. Assoc. J., September 12, 2006; 175(6): 611 - 617.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. J. Lamb, S. Vickery, and C. P. Price
Amino-Terminal Pro-Brain Natriuretic Peptide to Diagnose Congestive Heart Failure in Patients With Impaired Kidney Function
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1060 - 1061.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., June 1, 2006; 11(3): 95 - 96.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. A. Chen, M. J. Wood, D. G. Krauser, A. L. Baggish, R. Tung, S. Anwaruddin, M. H. Picard, and J. L. Januzzi
NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy
Eur. Heart J., April 1, 2006; 27(7): 839 - 845.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.